Bei unserem Medizinprodukte Update Webinar im November 2022 haben die Partner:innen Dr. Jörg Schickert, Arne Thiermann und Dr. Tanja Eisenblätter, sowie Associate Dr. Benjamin Goehl den Teilnehmenden Updates zu einer Reihe...more
Companies in the life sciences and health care industry, like most companies, navigated unparalleled challenges in 2020. But unlike other industries, they had to do so while simultaneously facing the biggest challenge of all...more
Change is coming to the life sciences industry. Price pressure, new market entrants, the emergence of personalized medicine, and even climate change are adding complexity to traditional manufacturing processes and supply...more
2/20/2018
/ Artificial Intelligence ,
Business Disruption ,
Cybersecurity ,
EU ,
Germany ,
Hackers ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Regulatory Standards ,
Risk Management ,
Supply Chain ,
UK Brexit
Last week, a staff retention survey was published, according to which certain contestants in the race for hosting the EMA were less liked by the EMA staff. And now the decision-making progress is going forward....more
10/6/2017
/ Biosimilars ,
Biotechnology ,
EU ,
European Medicines Agency (EMA) ,
Life Sciences ,
Medical Devices ,
Member State ,
Pharmaceutical Industry ,
Referendums ,
Regulatory Oversight ,
UK ,
UK Brexit
Blog Industries: Life Sciences and Healthcare By Dr. Tanja Eisenblätter EMA employees are taking precautions to avoid relocating to cities they consider less attractive, according to the results of a recent staff retention...more
Advertising is a major expenditure for pharmaceutical companies launching new products, but in the cutthroat European market, companies often try to gain competitive advantage by accusing competitors of engaging in false...more
The bids to host the EMA are in! We have reviewed all of them and give you our personal impressions on what to expect.
After the EMA has announced the development of a business continuity plan to deal with the workload...more